{
  "id": 12610798,
  "title": "Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2",
  "url": "https://urgent.news/2026/10/07/axsome-therapeutics-to-report-third-quarter-2026-financial-results-on",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-07T11:06:32.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/axsome-therapeutics-to-report-third-quarter-2026-financial-results-on-november-2"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Stella-Jones Will Hold a Conference Call to Discuss its Third Quarter 2026 Financial Results",
        "url": "https://urgent.news/2026/10/07/stella-jones-will-hold-a-conference-call-to-discuss-its-third-quarter",
        "published": "2026-10-07T10:06:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}